Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. - Test2 - elhamkhani - TriplyDB

Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.

Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.

http://www.wikidata.org/entity/Q35122028

about

Plasmid-determined AmpC-type beta-lactamases.The extended regulatory networks of SXT/R391 integrative and conjugative elements and IncA/C conjugative plasmids Mathematical model of plasmid-mediated resistance to ceftiofur in commensal enteric Escherichia coli of cattle Salmonella Typhimurium ST213 is associated with two types of IncA/C plasmids carrying multiple resistance determinants.blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids.Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003 Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei.Characterization of AmpC-mediated resistance in clinical Salmonella isolates recovered from humans during the period 1992 to 2003 in England and Wales.Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to production of CTX-M-14 and CMY-2 beta-lactamases.Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan.Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei.Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain.Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat Complete sequencing of IncI1 sequence type 2 plasmid pJIE512b indicates mobilization of blaCMY-2 from an IncA/C plasmid.Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998.Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii.Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate.Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan.Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan.Characterization of antimicrobial resistance of Salmonella Newport isolated from animals, the environment, and animal food products in Canada.Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins.Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates Colonization of extended-spectrum-β-lactamase- and NDM-1-producing Enterobacteriaceae among pregnant women in the community in a low-income country: a potential reservoir for transmission of multiresistant Enterobacteriaceae to neonates.Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene IncA/C plasmids: An emerging threat to human and animal health?Molecular epidemiology of blaCMY-2 plasmids carried by Salmonella enterica and Escherichia coli isolates from cattle in the Pacific Northwest Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada Extended-spectrum-cephalosporin resistance in Salmonella enterica isolates of animal origin CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid.

P2860

Q24535748-56BC3E05-54BE-4AD1-AD44-1237F09697D9 Q26782828-2834F30A-7523-4E5A-867C-AC824A89CB1F Q28483752-E693B972-0535-4FF5-8B82-BE0479D9E180 Q30995707-E6AEAA11-5CD4-408C-8740-40E460C1439D Q33613669-6DF51C5C-840F-469D-A8C6-74D18D989FD6 Q33690231-03B04C31-5137-4A23-83EE-1506128BDE58 Q33806371-15BC3E1A-54F9-49B5-BE6C-65BFDC65BD1F Q33856223-841F249C-62E7-463C-8855-1244615433C4 Q33859161-4F6B9E96-2E83-4F00-8C56-4EDBA4A7C916 Q33885089-A09DE788-C90A-4DC6-91AC-8267A6D748BC Q33970463-4F210048-8B0E-49B0-83D8-2967AA0F42BD Q33976310-6507E0A2-60ED-41BA-A839-1F04CA6838F3 Q33976916-B224DECA-95E2-4276-8F16-9C8C4B58FD31 Q33977370-8F7ADC4C-D064-4C31-A8E6-02B2B363CF21 Q33979601-F3F45187-BF44-4D66-973E-F37D34459D14 Q33979636-8AFFE180-A0AC-4FC1-B6E3-E07DA5550ED2 Q33980624-982AA332-D68A-4312-854F-20D9BA2DAF44 Q33980770-6C34E100-5949-4F24-8ED3-3A88D90065FE Q33983055-2B2120FF-0C23-4F8F-99DE-742DB2E0D996 Q33983776-1126E8A7-67B4-4121-9314-9A38AEFCFBBE Q34058055-893A8FA6-7680-451B-986F-1F689E4738CE Q34106653-F9F13E31-0B2F-4C50-91BB-442A7771EE1D Q34107174-DADF5776-3B6C-4774-A8F9-6EEC189E6694 Q34111500-5C1E68FE-2536-4FE4-A780-919D4FE5D85C Q34195633-C3A7D8D8-83D8-449A-BF91-9DD29B423F9A Q34219120-E8D0AA5E-FDAD-4283-A07B-A0BF0936AC6C Q34470756-EC586B67-1A85-40AC-837E-2489FA75D09F Q34989565-1C962312-00B8-4B3F-9A90-EF8F1B5DC032 Q35005180-087A6564-21C2-4C29-BF95-B89DF5465AC5 Q35125797-537CB3D7-DCD8-4A54-ACF9-B77E7A92033D Q35133558-DE12BA10-1F42-44EE-A8C5-CE6ED2AF011F Q35138291-8A3ECD46-EC51-4115-AB3B-21318D321711 Q35440638-CBCCB3CF-382B-43D9-98C3-16E0C37D2868 Q35607680-BF2D45E9-F1F9-4B2E-9F8C-37671F5B922D Q35685430-2B5C7837-C265-43F3-86DB-F849FC8F09C3 Q36059297-02B454E3-55D3-482C-BCC0-CFF2D52D5F93 Q36313492-3E133BF2-9EEF-4B6D-9D5B-996B7E59098D Q36501123-0BB87CB3-DA9D-4CCE-9E5F-259955FA76F9 Q36670258-A2714C36-F250-435E-827D-F1C9AD678B45 Q36670970-91002A4A-9C45-494C-88B4-8CB45AF37E6C

P2860

Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.

http://www.wikidata.org/entity/Q35122028

description

1996 nî lūn-bûn

@nan

1996 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Characterization of the plasmi ...... ble for cephamycin resistance.

@ast

Characterization of the plasmi ...... ble for cephamycin resistance.

@en

type

label

Characterization of the plasmi ...... ble for cephamycin resistance.

@ast

Characterization of the plasmi ...... ble for cephamycin resistance.

@en

prefLabel

Characterization of the plasmi ...... ble for cephamycin resistance.

@ast

Characterization of the plasmi ...... ble for cephamycin resistance.

@en

P1433

Q35122028-EC5D7E66-2864-4BAE-AE47-03591CE33618

P1476

Q35122028-7AB4A3D0-569A-4F90-AA2F-45CBD694D72B

P2093

Q35122028-1C9007A7-EB24-4B86-981A-72F682DBC731

Q35122028-B019E5FB-EC3F-48BC-AC60-2966267F5059

Q35122028-B6E68AE6-E463-47C0-9484-0EBC7FBBC6D9

Q35122028-FDA3327C-9EDD-4521-8629-966427C65ADA

P2860

Q35122028-08A333A8-1588-4246-9F78-5D4FBCF904F6

Q35122028-14D751A2-7344-4E6C-ABEC-69E40021A49B

Q35122028-18A83F24-B4D5-40FF-AE1A-CD4692A9C4BF

Q35122028-425A6ED5-9D54-4008-9F50-AA034453FEA1

Q35122028-5596A644-7A1F-4F47-8918-A9AF0CECD3F1

Q35122028-583F017F-2342-483B-B178-B9C23F4005AF

Q35122028-5C36A88F-E75F-4D63-9AF3-F188DB3A7F39

Q35122028-6E69D4F0-ECBC-4C3F-A7F8-0951AF670D09

Q35122028-766ADCDF-E45A-43EC-A053-065306B2B8A9

Q35122028-B81E34CB-EA67-49A5-9F47-53D3417AC6AA

P304

Q35122028-190E7F32-3C00-4A34-B662-5FF40576DCD8

P31

Q35122028-B0BA50E5-26EF-4BD2-8E5A-3F1216BA8732

P356

Q35122028-7C936B55-C53B-45A7-A124-47B8409E19C7

P407

Q35122028-91BA824F-B423-421C-96D4-0F15ADD71716

P433

Q35122028-828D452C-30F1-44A4-A733-8FC32C8231CF

P478

Q35122028-169AC286-5CD5-4028-A15C-3884BA9F278F

P577

Q35122028-2219A00F-6BFF-4D1A-A969-D40F1846C810

P698

Q35122028-329FD9F9-653F-43AF-9D9C-12A96CD0880F

P932

Q35122028-4EABFD2E-E6BF-4A27-B8C6-23E573EA6B28

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Characterization of the plasmi ...... ible for cephamycin resistance

@en

P2093

Bauernfeind A

http://www.w3.org/2001/XMLSchema#string

Giamarellou H

http://www.w3.org/2001/XMLSchema#string

Jungwirth R

http://www.w3.org/2001/XMLSchema#string

Stemplinger I

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid alkaline extraction procedure for screening recombinant plasmid DNA

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

A functional classification scheme for beta-lactamases and its correlation with molecular structure

Fast and sensitive multiple sequence alignments on a microcomputer

Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants.

The structure of beta-lactamases.

ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type

More extended-spectrum beta-lactamases

Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta-lactamase gene in Escherichia coli BS.

The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

P304

221-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.40.1.221

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1996-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8787910

http://www.w3.org/2001/XMLSchema#string

P932

163087

http://www.w3.org/2001/XMLSchema#string